Identification of vaccine candidate antigens from a genomic analysis of Porphyromonas gingivalis

被引:97
作者
Ross, BC
Czajkowski, L
Hocking, D
Margetts, M
Webb, E
Rothel, L
Patterson, M
Agius, C
Camuglia, S
Reynolds, E
Littlejohn, T
Gaeta, B
Ng, A
Kuczek, ES
Mattick, JS
Gearing, D
Barr, IG
机构
[1] CSL Ltd, Res & Dev, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Sch Dent Sci, Melbourne, Vic 3000, Australia
[3] Univ Sydney, Australian Natl Genom Informat Serv, Sydney, NSW 2006, Australia
[4] Univ Queensland, Australian Genome Res Facil, Brisbane, Qld 4072, Australia
[5] Univ Queensland, Inst Mol Biosci, ARC Special Res Ctr Funct & Appl Genom, Brisbane, Qld 4072, Australia
关键词
bioinformatics; genomics; vaccine;
D O I
10.1016/S0264-410X(01)00173-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Porphyromonas gingivalis is a key periodontal pathogen which has been implicated in the etiology of chronic adult periodontitis. Our aim was to develop a protein based vaccine for the prevention and or treatment of this disease. We used a whole genome sequencing approach to identify potential vaccine candidates. From a genomic sequence, we selected 120 genes using a series of bioinformatics methods. The selected genes were cloned for expression in Escherichia coli and screened with P. gingivalis antisera before purification and testing in an animal model. Two of these recombinant proteins (PG32 and PG33) demonstrated significant protection in the animal model, while a number were reactive with various antisera. This process allows the rapid identification of vaccine candidates from genomic data. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:4135 / 4142
页数:8
相关论文
共 19 条
[1]   Detection of identical ribotypes of Porphyromonas gingivalis in patients residing in the United States, Sudan, Romania and Norway [J].
Ali, RW ;
Martin, L ;
Haffajee, AD ;
Socransky, SS .
ORAL MICROBIOLOGY AND IMMUNOLOGY, 1997, 12 (02) :106-111
[2]  
Ausubel FM, 1995, CURRENT PROTOCOLS MO
[3]   PROTECTIVE IMMUNITY TO PORPHYROMONAS-GINGIVALIS INFECTION IN A MURINE MODEL [J].
BIRD, PS ;
GEMMELL, E ;
POLAK, B ;
PATON, RG ;
SOSROSENO, W ;
SEYMOUR, GJ .
JOURNAL OF PERIODONTOLOGY, 1995, 66 (05) :351-362
[4]  
BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1016/0168-6445(95)00003-U
[5]   WHOLE-GENOME RANDOM SEQUENCING AND ASSEMBLY OF HAEMOPHILUS-INFLUENZAE RD [J].
FLEISCHMANN, RD ;
ADAMS, MD ;
WHITE, O ;
CLAYTON, RA ;
KIRKNESS, EF ;
KERLAVAGE, AR ;
BULT, CJ ;
TOMB, JF ;
DOUGHERTY, BA ;
MERRICK, JM ;
MCKENNEY, K ;
SUTTON, G ;
FITZHUGH, W ;
FIELDS, C ;
GOCAYNE, JD ;
SCOTT, J ;
SHIRLEY, R ;
LIU, LI ;
GLODEK, A ;
KELLEY, JM ;
WEIDMAN, JF ;
PHILLIPS, CA ;
SPRIGGS, T ;
HEDBLOM, E ;
COTTON, MD ;
UTTERBACK, TR ;
HANNA, MC ;
NGUYEN, DT ;
SAUDEK, DM ;
BRANDON, RC ;
FINE, LD ;
FRITCHMAN, JL ;
FUHRMANN, JL ;
GEOGHAGEN, NSM ;
GNEHM, CL ;
MCDONALD, LA ;
SMALL, KV ;
FRASER, CM ;
SMITH, HO ;
VENTER, JC .
SCIENCE, 1995, 269 (5223) :496-512
[6]  
Fox C H, 1992, Curr Opin Dent, V2, P5
[7]   Prevalence of Porphyromonas gingivalis and periodontal health status [J].
Griffen, AL ;
Becker, MR ;
Lyons, SR ;
Moeschberger, ML ;
Leys, EJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (11) :3239-3242
[8]   PERIODONTAL BONE LEVEL AND GINGIVAL PROTEINASE ACTIVITY IN GNOTOBIOTIC-RATS IMMUNIZED WITH BACTEROIDES-GINGIVALIS [J].
KLAUSEN, B ;
EVANS, RT ;
RAMAMURTHY, NS ;
GOLUB, LM ;
SFINTESCU, C ;
LEE, JY ;
BEDI, G ;
ZAMBON, JJ ;
GENCO, RJ .
ORAL MICROBIOLOGY AND IMMUNOLOGY, 1991, 6 (04) :193-201
[9]   Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers [J].
Mansouri, E ;
Gabelsberger, J ;
Knapp, B ;
Hundt, E ;
Lenz, U ;
Hungerer, KD ;
Gilleland, HE ;
Staczek, J ;
Domdey, H ;
von Specht, BU .
INFECTION AND IMMUNITY, 1999, 67 (03) :1461-1470
[10]   EXPERT SYSTEM FOR PREDICTING PROTEIN LOCALIZATION SITES IN GRAM-NEGATIVE BACTERIA [J].
NAKAI, K ;
KANEHISA, M .
PROTEINS-STRUCTURE FUNCTION AND GENETICS, 1991, 11 (02) :95-110